{"id":113034,"date":"2021-04-30T13:00:00","date_gmt":"2021-04-30T13:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=28667062866706"},"modified":"2021-04-30T13:00:00","modified_gmt":"2021-04-30T13:00:00","slug":"given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/","title":{"rendered":"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030"},"content":{"rendered":"<p><img decoding=\"async\" width=\"180\" height=\"180\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/04\/4671-roots-analysis-squarelogo-14685651750522028129-9.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p><em>The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available \/ under development to mitigate the aforementioned concerns and simplify the management of biopharmaceutical supply chains.<\/em><\/p>\n<p><strong><em>To order this 510+ page report, which features 185+ figures and 400+ tables, please visit this<\/em><\/strong> \u2013 <a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapies-supply-chain\/260.html\">https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapies-supply-chain\/260.html<\/a><\/p>\n<p>The USD 1.5 billion (by 2030) financial opportunity within the cell and advanced therapy supply chain management software solutions market has been analyzed across the following segments:<\/p>\n<ul>\n<li>Application area<\/li>\n<li>Sample collection and processing<\/li>\n<li>Manufacturing<\/li>\n<li>Logistics<\/li>\n<li>Patient identification and treatment follow-up<\/li>\n<\/ul>\n<p>Type of software solution<\/p>\n<ul>\n<li>Cell orchestration platform<\/li>\n<li>Enterprise manufacturing system<\/li>\n<li>Inventory management system<\/li>\n<li>Laboratory information management system<\/li>\n<li>Logistics management system<\/li>\n<li>Patient management system<\/li>\n<li>Quality management system<\/li>\n<\/ul>\n<p>Mode of Deployment<\/p>\n<ul>\n<li>Cloud-based solution<\/li>\n<li>On-premises solution<\/li>\n<\/ul>\n<p>Scale of Operation<\/p>\n<ul>\n<li>Clinical<\/li>\n<li>Commercial<\/li>\n<\/ul>\n<p>End user<\/p>\n<ul>\n<li>Biobank<\/li>\n<li>Cell therapy lab \/ commercial organization<\/li>\n<li>Hospital \/ medical center<\/li>\n<li>Research institute<\/li>\n<\/ul>\n<p>Key geographical regions<\/p>\n<ul>\n<li>North America<\/li>\n<li>Europe<\/li>\n<li>Asia Pacific<\/li>\n<li>Rest of the world<\/li>\n<\/ul>\n<p><strong>The <\/strong><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapies-supply-chain\/260.html\">Cell and Advanced Therapies Supply Chain Management Market<\/a>: Focus on Technological Solutions (Cell Orchestration Platforms, Enterprise Manufacturing Systems, Inventory Management Systems, Laboratory Information Management Systems, Logistics Management Systems, Patient Management Systems, Quality Management Systems, Tracking &#038; Tracing Systems, and Other Software), 2019-2030 <strong>report features the following companies, which we identified to be key players in this domain:<\/strong><\/p>\n<ul>\n<li>Be The Match BioTherapies\u00ae<\/li>\n<li>Brooks Life Sciences<\/li>\n<li>Clarkston Consulting<\/li>\n<li>Cryoport<\/li>\n<li>Haemonetics<\/li>\n<li>Hypertrust Patient Data Care<\/li>\n<li>Lykan Bioscience<\/li>\n<li>MAK-SYSTEM<\/li>\n<li>MasterControl<\/li>\n<li>SAP<\/li>\n<li>SAVSU Technologies<\/li>\n<li>sedApta Group<\/li>\n<li>Stafa Cellular Therapy<\/li>\n<li>Title21 Health Solutions<\/li>\n<li>TraceLink<\/li>\n<li>TrakCel<\/li>\n<li>Vineti<\/li>\n<\/ul>\n<p><strong>Table of Contents<\/strong><\/p>\n<ol>\n<li><strong>Preface<\/strong><\/li>\n<li><strong>Executive Summary<\/strong><\/li>\n<li><strong> Introduction<\/strong><\/li>\n<li><strong> Current Market Landscape<\/strong><\/li>\n<li><strong> Company Competitiveness Analysis<\/strong><\/li>\n<li><strong> Cell and Advanced Therapies Supply Chain Management: Company Profiles<\/strong><\/li>\n<li><strong> Supply Chain Orchestration Platform: Emerging Trends and Key Players<\/strong><\/li>\n<li><strong> Finding and Investment Analysis<\/strong><\/li>\n<li><strong> Partnerships and Collaborations<\/strong><strong>\u00a0<\/strong><\/li>\n<li><strong> Supply Chain Utilization Use Cases<\/strong><\/li>\n<li><strong> Stakeholder Needs Analysis <\/strong><\/li>\n<li><strong> Cost Savings Analysis <\/strong><\/li>\n<li><strong> Market Forecast<\/strong><\/li>\n<li><strong> Executive Insights<\/strong><\/li>\n<li><strong> Concluding Remarks<\/strong><\/li>\n<li><strong> Appendix 1: List of Additional Supply Chain Management Software Solutions <\/strong><\/li>\n<\/ol>\n<p><strong>\u00a0<\/strong><strong>Appendix 2: Tabulated Data<\/strong><\/p>\n<ol start=\"18\">\n<li><strong> Appendix 3: List of Companies and Organizations<\/strong><\/li>\n<\/ol>\n<p>To purchase a copy, please visit <a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapies-supply-chain\/260.html\">https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapies-supply-chain\/260.html<\/a><\/p>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Gaurav Chaudhary<br \/> gaurav.chaudhary@rootsanalysis.com<br \/> Roots Analysis<br \/> A430, 4th Floor,<br \/> Bestech Business Towers, Sector 66, Mohali, India<br \/> sales@rootsanalysis.com<br \/> +1 (415) 800 3415<br \/> +44 (122) 391 1091<br \/> Web: https:\/\/www.rootsanalysis.com\/<br \/> LinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis<br \/> Twitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/\">Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available \/ under development to mitigate the aforementioned concerns and simplify the management of biopharmaceutical supply chains. To order this 510+ [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2\/\">Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-113034","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 - Business\" \/>\n<meta property=\"og:description\" content=\"The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available \/ under development to mitigate the aforementioned concerns and simplify the management of biopharmaceutical supply chains. To order this 510+ [&hellip;] The post Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-30T13:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/04\/4671-roots-analysis-squarelogo-14685651750522028129-9.png\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/\",\"name\":\"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/04\/4671-roots-analysis-squarelogo-14685651750522028129-9.png\",\"datePublished\":\"2021-04-30T13:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/04\/4671-roots-analysis-squarelogo-14685651750522028129-9.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/04\/4671-roots-analysis-squarelogo-14685651750522028129-9.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/","og_locale":"en_US","og_type":"article","og_title":"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 - Business","og_description":"The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available \/ under development to mitigate the aforementioned concerns and simplify the management of biopharmaceutical supply chains. To order this 510+ [&hellip;] The post Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/","og_site_name":"Business","article_published_time":"2021-04-30T13:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/04\/4671-roots-analysis-squarelogo-14685651750522028129-9.png","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/","url":"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/","name":"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030 - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/04\/4671-roots-analysis-squarelogo-14685651750522028129-9.png","datePublished":"2021-04-30T13:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/04\/4671-roots-analysis-squarelogo-14685651750522028129-9.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/04\/4671-roots-analysis-squarelogo-14685651750522028129-9.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2021\/04\/30\/given-the-cost-saving-potential-across-different-processes-and-operations-the-cell-and-advanced-therapies-supply-chain-management-market-is-projected-to-grow-at-an-annualized-rate-of-25-rapid-till-2-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/113034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=113034"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/113034\/revisions"}],"predecessor-version":[{"id":113035,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/113034\/revisions\/113035"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=113034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=113034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=113034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}